GenPath logo in conjunction with urology

Bladder Cancer

Bladder cancer is three times more common in men than in women. If there is a history of recurrent idiopathic hematuria (blood in urine) or bladder cancer with your patient, GenPath offers testing that can aid in diagnosis and monitoring of bladder cancer.

Test CodeTest Name
5254-8Urine Cytology
5030-2UroVysion® – Bladder Cancer (FISH), voided urine
5324-9Comprehensive Urine Pathology (Urine Cytology and UroVysion)
TF89-0hTERT (Human Telomerase Reverse Transcriptase)
©2019 GenPath, a division of BioReference Laboratories Inc., an OPKO Health Company